TAS2R12P (Gene)

Entrez:266656

Description:taste 2 receptor member 12, pseudogene

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View TAS2R12P's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with TAS2R12P.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using TAS2R12P.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for TAS2R12P.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with TAS2R12P.

Results found

Linked to

	Label	Description
	GSE119705 adenosine natural killer cell 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147816 GSE147817 LSD1 inhibition McCoy 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183535 MYC inhibition HeLa 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 4 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE149359 ASAP2 knockout MIA PaCa-2 PANC-1 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GPR89A IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	TAS2R13 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE186486 SF3B1 DDX42 overexpression HEK293T 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147816 GSE147817 LSD1 inhibition McCoy 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 12 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE119705 adenosine natural killer cell 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147816 GSE147817 LSD1 inhibition McCoy 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE183535 MYC inhibition HeLa 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 4 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE149359 ASAP2 knockout MIA PaCa-2 PANC-1 3 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GPR89A IDG ionchannel ARCHS4 coexpression

Gene Set (Entity type)

A Gene Set from IDG

TAS2R13 IDG GPCR ARCHS4 coexpression

Gene Set (Entity type)

A Gene Set from IDG

GSE186486 SF3B1 DDX42 overexpression HEK293T 3 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE147816 GSE147817 LSD1 inhibition McCoy 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE233679 nicotinamide 12 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.